Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Arterial stiffness association with chronic inflammatory disorders in the UK Biobank study

View through CrossRef
Objective The present study tested the hypothesis that arterial stiffness will be elevated across overall and specific inflammatory disorders compared with an inflammation-free comparison group. Methods Adults (n=171 125) aged 40–70 years from the UK Biobank who were cardiovascular disease (CVD) free and who had their arterial stiffness assessed at the time of study recruitment between 2006 and 2010 were included. The main exposure was represented by a global measure of chronic inflammatory disorders. Two inflammatory biomarker measures (eg, leucocytes count, granulocytes count) were included as markers of inflammation severity. The arterial stiffness index assessed by a non-invasive technique represented the study primary outcome measure. Results A total of 5976 (3%) participants diagnosed with inflammatory disorders and 165 149 participants without an inflammatory disorder had data on arterial stiffness. Adjusted linear regression analyses revealed a 14% increment in mean arterial stiffness for chronic inflammatory disorders (beta coefficient (β) 1.14, 95% CI 1.05 to 1.24, P=0.002) compared with no chronic inflammatory disorder. Arterial stiffness tended to increase (P value=0.031) with tertiles of leucocytes and granulocytes count. For instance, mean arterial stiffness values increased from 1.11 (95% CI 0.96 to 1.29) in the first tertile to 1.17 (95% CI 1.02 to 1.34) in the second tertile, and 1.21 (95% CI 1.05 to 1.39) in the third tertile of leucocytes count. There was evidence for similar associations with some of the most common individual inflammatory disorders, including psoriasis and rheumatoid arthritis. Conclusion Arterial stiffness was associated with multiple chronic inflammatory disorders. An increasing trend in mean arterial stiffness was also documented with increasing tertiles of different inflammatory biomarkers. Future studies are needed to investigate the discriminant value of arterial stiffness to predict major CVD events within various inflammatory disorders.
Title: Arterial stiffness association with chronic inflammatory disorders in the UK Biobank study
Description:
Objective The present study tested the hypothesis that arterial stiffness will be elevated across overall and specific inflammatory disorders compared with an inflammation-free comparison group.
Methods Adults (n=171 125) aged 40–70 years from the UK Biobank who were cardiovascular disease (CVD) free and who had their arterial stiffness assessed at the time of study recruitment between 2006 and 2010 were included.
The main exposure was represented by a global measure of chronic inflammatory disorders.
Two inflammatory biomarker measures (eg, leucocytes count, granulocytes count) were included as markers of inflammation severity.
The arterial stiffness index assessed by a non-invasive technique represented the study primary outcome measure.
Results A total of 5976 (3%) participants diagnosed with inflammatory disorders and 165 149 participants without an inflammatory disorder had data on arterial stiffness.
Adjusted linear regression analyses revealed a 14% increment in mean arterial stiffness for chronic inflammatory disorders (beta coefficient (β) 1.
14, 95% CI 1.
05 to 1.
24, P=0.
002) compared with no chronic inflammatory disorder.
Arterial stiffness tended to increase (P value=0.
031) with tertiles of leucocytes and granulocytes count.
For instance, mean arterial stiffness values increased from 1.
11 (95% CI 0.
96 to 1.
29) in the first tertile to 1.
17 (95% CI 1.
02 to 1.
34) in the second tertile, and 1.
21 (95% CI 1.
05 to 1.
39) in the third tertile of leucocytes count.
There was evidence for similar associations with some of the most common individual inflammatory disorders, including psoriasis and rheumatoid arthritis.
Conclusion Arterial stiffness was associated with multiple chronic inflammatory disorders.
An increasing trend in mean arterial stiffness was also documented with increasing tertiles of different inflammatory biomarkers.
Future studies are needed to investigate the discriminant value of arterial stiffness to predict major CVD events within various inflammatory disorders.

Related Results

Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Assessment of arterial stiffness in populations at increased cardiovascular risk
Assessment of arterial stiffness in populations at increased cardiovascular risk
<p dir="ltr">Introduction</p><p dir="ltr">Arterial stiffness is an established marker of cardiovascular risk. However, its full potential for clinical application...
Assessment of arterial stiffness in populations at increased cardiovascular risk
Assessment of arterial stiffness in populations at increased cardiovascular risk
<p dir="ltr">Introduction</p><p dir="ltr">Arterial stiffness is an established marker of cardiovascular risk. However, its full potential for clinical application...
RNA-sequencing analysis of differential gene expression associated with arterial stiffness
RNA-sequencing analysis of differential gene expression associated with arterial stiffness
Objectives Arterial stiffness is recognized as an important predictor of cardiovascular disease morbidity and mortality, independent of traditional cardiovascul...
Arterial Stiffness Assessed by Cardio-Ankle Vascular Index
Arterial Stiffness Assessed by Cardio-Ankle Vascular Index
Arterial stiffness is an age-related disorder. In the medial layer of arteries, mechanical fracture due to fatigue failure for the pulsatile wall strain causes medial degeneration ...
Cohort profile: A Québec-based plasma donor biobank to study COVID-19 immunity (PlasCoV)
Cohort profile: A Québec-based plasma donor biobank to study COVID-19 immunity (PlasCoV)
AbstractPurposeLong-term humoral immunity to COVID-19 is not well understood owing to the continuous emergence of new variants of concern, the evolving vaccine- and infection-induc...
Prevention and treatment of excessive arterial stiffness
Prevention and treatment of excessive arterial stiffness
Abstract Arterial stiffness affecting mainly the aorta and its large branches is currently the subject of numerous studies. Over the years, such arterial stiffnes...
Subclinical arterial stiffness in prehypertensives
Subclinical arterial stiffness in prehypertensives
Objective To assess the difference of arterial stiffness in prehypertensive subjects in comparison to normotensive subjects. ...

Back to Top